Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements
This document provides guidance on brand name assessment, inner and outer product labels, and risk management planning.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2022-07-28
Data overview
- Formats
- HTML
- File languages
- English, French